Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 404

1.

Assessment of safety of the major antimalarial drugs.

Chattopadhyay R, Mahajan B, Kumar S.

Expert Opin Drug Saf. 2007 Sep;6(5):505-21. Review.

PMID:
17877439
2.

Antimalarial drugs: current status and new developments.

Rathore D, McCutchan TF, Sullivan M, Kumar S.

Expert Opin Investig Drugs. 2005 Jul;14(7):871-83. Review.

PMID:
16022576
3.

Antimalarial compounds: from bench to bedside.

Olliaro PL, Taylor WR.

J Exp Biol. 2003 Nov;206(Pt 21):3753-9. Review.

4.

Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.

Na-Bangchang K, Karbwang J.

Fundam Clin Pharmacol. 2009 Aug;23(4):387-409. doi: 10.1111/j.1472-8206.2009.00709.x. Review.

PMID:
19709319
5.

Modulators of the efficacy and toxicity of drugs in malaria treatment.

Nzila A, Chilengi R.

Trends Pharmacol Sci. 2010 Jun;31(6):277-83. doi: 10.1016/j.tips.2010.03.002. Epub 2010 Apr 9. Review.

PMID:
20381886
6.

Antimalarial dosing regimens and drug resistance.

Barnes KI, Watkins WM, White NJ.

Trends Parasitol. 2008 Mar;24(3):127-34. doi: 10.1016/j.pt.2007.11.008. Epub 2008 Feb 11. Review.

PMID:
18262470
7.

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.

Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG.

Malar J. 2008 Jun 11;7:106. doi: 10.1186/1475-2875-7-106.

8.

Chemoprophylaxis of malaria.

Brown GV.

Med J Aust. 1993 Aug 2;159(3):187-96. Review.

PMID:
8336621
9.

Economic implications of resistance to antimalarial drugs.

Phillips M, Phillips-Howard PA.

Pharmacoeconomics. 1996 Sep;10(3):225-38.

PMID:
10163571
10.

World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ.

Malar J. 2007 Sep 6;6:121.

12.

Treatment and prevention of malaria in pregnancy: opportunities and challenges.

Rogerson SJ, Menendez C.

Expert Rev Anti Infect Ther. 2006 Aug;4(4):687-702.

PMID:
17009946
13.

The safety of amodiaquine use in pregnant women.

Tagbor HK, Chandramohan D, Greenwood B.

Expert Opin Drug Saf. 2007 Nov;6(6):631-5. Review.

PMID:
17967151
14.

Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.

Ogbonna A, Uneke CJ.

Trans R Soc Trop Med Hyg. 2008 Jul;102(7):621-7. doi: 10.1016/j.trstmh.2008.03.024. Epub 2008 May 21. Review.

PMID:
18499204
16.

[Therapeutic efficacy of amodiaquine against uncomplicated malaria in Madagascar].

Randriamanantena A, Randrianasolo L, Vonimpaisomihanta JA, Tafangy PB, Bayant Z, Randrianarivelojosia M.

Sante. 2007 Apr-Jun;17(2):75-8. French.

PMID:
17962154
17.

Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.

Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO.

Malar J. 2008 Jun 11;7:107. doi: 10.1186/1475-2875-7-107.

18.

Challenges in malaria control in sub-Saharan Africa: the vaccine perspective.

Lusingu JP, Von Seidlein L.

Tanzan J Health Res. 2008 Oct;10(4):253-66.

PMID:
19402588
19.

Pharmacodynamics of antimalarial chemotherapy.

Na-Bangchang K.

Expert Rev Clin Pharmacol. 2009 Sep;2(5):491-515. doi: 10.1586/ecp.09.27.

PMID:
22112224
20.

[Antimalarial chemoprophylaxis in children].

Orlando R, Tiseo D, Tosone G, Cangiano F, Scordino F.

Minerva Pediatr. 1989 Dec;41(12):577-9. Review. Italian.

PMID:
2699513
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk